NURALOGIX
"NURALOGIX" is a word mark owned by Nuralogix Corporation, filed at the CIPO on March 4, 2020. It is registered and covers classes 9, 10, 42 and 44.
- Status
- Registered
- Since March 11, 2026
- Filed
- March 4, 2020
- Registered
- March 11, 2026
- Expires
- March 11, 2036
- Application no.
- 2015329
- Registration no.
- TMA1392661
- Office
- CIPO
- Canadian Intellectual Property Office
- Mark type
- Word mark
- 4 classes
Who owns NURALOGIX
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Nuralogix Corporation
Canada
Representative
Bhole IP Law
Bhole IP Law
What the mark covers
The products and services NURALOGIX is filed for, grouped by Nice class.
Downloadable computer software for use in providing healthcare information, namely blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, and emotional health; downloadable computer software for providing medical information, namely blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, and emotional health; downloadable computer software for health assessment, namely, for detecting, measuring, evaluating and identifying emotion, sentiment, deception, emotional expressions, emotional reactions, facial expressions, facial expression signals, blood flow, physiological signals, and physiological expressions, namely, for use in medical diagnostics, medical imaging, and behavioural analysis; downloadable computer software for medical information, namely reporting and interpreting health care data, namely, blood flow, blood pressure, heart rate, physiological activity, physiological stress, and psychological markers; downloadable computer software for use in measurement of biometric data, namely, blood flow, blood pressure, heart rate, physiological activity, physiological stress, and psychological markers; downloadable computer software for measuring and interpreting human health data, namely blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, emotional health; downloadable computer software for use in contactless health data determination, namely, for detecting, measuring, evaluating and identifying emotion, sentiment, deception, emotional expressions, emotional reactions, facial expressions, facial expression signals, blood flow, physiological signals, and physiological expressions, namely, for use in medical diagnostics, medical imaging, and behavioural analysis; downloadable computer software for use in predicting health risks; downloadable computer software for use in analyzing hemoglobin concentration; downloadable computer software for use in accessing and reviewing health data, namely blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, and emotional health; downloadable computer software for use in detecting health abnormalities, namely, health abnormalities relating to blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, and emotional health; downloadable applications for handheld computers, wearable computers, laptop computers, desktop computers, and mobile phones for physiological signal measurement, namely, for measuring blood flow, blood pressure, heart rate, physiological activity and physiological stress; downloadable computer software for providing health self-assessment, namely, image analysis detecting, measuring, evaluating and identifying emotion, sentiment, deception, emotional expressions, emotional reactions, facial expressions, facial expression signals, blood flow, physiological signals, and physiological expressions; downloadable applications for handheld computers, wearable computers, laptop computers, desktop computers, and mobile phones for physiological signal measurement, namely, for measuring blood flow, blood pressure, heart rate, physiological activity and physiological stress;
Devices for medical use to measure human biometric data, namely blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, emotional health; devices for medical use for non-invasive measuring of human biometric data, namely, blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, emotional health; devices for medical use for analyzing hemoglobin concentration; devices for medical use for detecting health abnormalities, namely health abnormalities relating to blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, and emotional health;
Software as a service (SAAS) services featuring software for use in providing healthcare information, namely blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, and emotional health; Software as a service (SAAS) services featuring software for providing medical information, namely blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, and emotional health; Software as a service (SAAS) services featuring software for health assessment, namely, for detecting, measuring, evaluating and identifying emotion, sentiment, deception, emotional expressions, emotional reactions, facial expressions, facial expression signals, blood flow, physiological signals, and physiological expressions, namely, for use in medical diagnostics, medical imaging, and behavioural analysis; Software as a service (SAAS) services featuring software for medical information, namely reporting and interpreting health care data, namely, blood flow, blood pressure, heart rate, physiological activity, physiological stress, and psychological markers; Software as a service (SAAS) services featuring software for use in measurement of biometric data, namely, blood flow, blood pressure, heart rate, physiological activity, physiological stress, and psychological markers; Software as a service (SAAS) services featuring software for measuring and interpreting human health data, namely blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, emotional health; Software as a service (SAAS) services featuring software for use in contactless health data determination, namely, for detecting, measuring, evaluating and identifying emotion, sentiment, deception, emotional expressions, emotional reactions, facial expressions, facial expression signals, blood flow, physiological signals, and physiological expressions, namely, for use in medical diagnostics, medical imaging, and behavioural analysis; Software as a service (SAAS) services featuring software for use in predicting health risks; Software as a service (SAAS) services featuring software for use in analyzing hemoglobin concentration; Software as a service (SAAS) services featuring software for use in accessing and reviewing health data, namely blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, and emotional health; Software as a service (SAAS) services featuring software for use in detecting health abnormalities namely, health abnormalities relating to blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, and emotional health; Software as a service (SAAS) services featuring software for providing health self-assessment, namely, image analysis detecting, measuring, evaluating and identifying emotion, sentiment, deception, emotional expressions, emotional reactions, facial expressions, facial expression signals, blood flow, physiological signals, and physiological expressions;
Providing medical information, namely blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, and emotional health; providing healthcare information, namely blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, and emotional health; medical screening services; health assessment services, namely, detecting, measuring, evaluating and identifying emotion, sentiment, deception, emotional expressions, emotional reactions, facial expressions, facial expression signals, blood flow, physiological signals, and physiological expressions, namely, for use in medical diagnostics, medical imaging, and behavioural analysis; medical diagnostic testing, monitoring and reporting services; medical information services, namely reporting and interpreting health care results, namely, health care results relating to blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, and emotional health; provision of medical information related to blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, emotional health; providing healthcare information from image analysis, namely, detecting, measuring, evaluating and identifying emotion, sentiment, deception, emotional expressions, emotional reactions, facial expressions, facial expression signals, blood flow, physiological signals, and physiological expressions; electronic processing of health care information, namely blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, and emotional health; providing information in the field of healthcare, namely blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, and emotional health;
What has happened so far
Steps recorded by the CIPO, newest first.
- Registered
- Registration Pending
- Advertised; Vol.72 Issue 3713
- Approval Notice Sent; APPROVED BY PROGRAM EX200M1
- Approved; APPROVED BY PROGRAM EX200M1
- Correspondence Created
- Correspondence Created
- Examiner's First Report
- Search Recorded
- Pre-Assessment Letter Sent; Retired Goods or Services
5 earlier steps on the official record.
About NURALOGIX
Who owns the trademark "NURALOGIX"?
The CIPO trademark "NURALOGIX" (application 2015329) is owned by Nuralogix Corporation.
What is the status of "NURALOGIX"?
Its status at the CIPO is: registered.
When was "NURALOGIX" registered?
It was registered on March 11, 2026 and is due to expire on March 11, 2036.
Get this data via the API
Everything on this page comes from the Signa API. Pull NURALOGIX and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019deb2a-6969-75b5-a19c-1579688b1479
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019deb2a-6969-75b5-a19c-1579688b1479",
"object": "trademark",
"mark_text": "NURALOGIX",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "CA",
"application_number": "2015329",
"filing_date": "2020-03-04",
"nice_classes": [
9,
10,
42,
44
],
"owners": [
{
"name": "NURALOGIX CORPORATION",
"entity_id": "ent_019eb7e0-e2de-721d-87e9-965a657c53e1"
}
]
}